Cohen Klingenstein’s CME Group CME Stock Holding History

Cohen Klingenstein’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,200	Closed	-$1.15M	–	213
2024 Q3	$1.15M	Hold	5,200	–	–	0.04%	163
2024 Q2	$1.02M	Hold	5,200	–	–	0.04%	165
2024 Q1	$1.12M	Hold	5,200	–	–	0.04%	163
2023 Q4	$1.1M	Hold	5,200	–	–	0.04%	161
2023 Q3	$1.04M	Hold	5,200	–	–	0.05%	159
2023 Q2	$964K	Hold	5,200	–	–	0.04%	170
2023 Q1	$996K	Hold	5,200	–	–	0.05%	162
2022 Q4	$874K	Hold	5,200	–	–	0.04%	168
2022 Q3	$921K	Hold	5,200	–	–	0.05%	160
2022 Q2	$1.06M	Hold	5,200	–	–	0.05%	156
2022 Q1	$1.24M	Hold	5,200	–	–	0.05%	154
2021 Q4	$1.19M	Hold	5,200	–	–	0.05%	161
2021 Q3	$1.01M	Hold	5,200	–	–	0.04%	179
2021 Q2	$1.11M	Hold	5,200	–	–	0.05%	175
2021 Q1	$1.06M	Hold	5,200	–	–	0.05%	174
2020 Q4	$947K	Hold	5,200	–	–	0.05%	173
2020 Q3	$870K	Hold	5,200	–	–	0.05%	173
2020 Q2	$845K	Hold	5,200	–	–	0.05%	169
2020 Q1	$899K	Hold	5,200	–	–	0.07%	150
2019 Q4	$1.04M	Hold	5,200	–	–	0.06%	158
2019 Q3	$1.1M	Buy	+5,200	New	+$1.09M	0.07%	150

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cohen Klingenstein's CME Position: Q4 2024 in Review

Cohen Klingenstein sold out of CME Group (CME) in Q4 2024, closing a stake of 5,200 shares — an estimated $1.15M sold.

Cohen Klingenstein first reported a position in CME in Q3 2019 and held it in 21 quarters. The position peaked at $1.24M in Q1 2022. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

Cohen Klingenstein reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
Cohen Klingenstein sold 5,200 CME Group shares in Q4 2024, an estimated $1.15M.
Cohen Klingenstein first reported a position in CME Group in Q3 2019 and held it in 21 quarters.
Cohen Klingenstein's CME Group position peaked at $1.24M in Q1 2022.
1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on Cohen Klingenstein's 13F filing for Q4 2024, filed 15 Jan 2025.